ENOCHIAN BIOSCIENCES INC's ticker is ENOB and the CUSIP is 29350E104. A total of 30 filers reported holding ENOCHIAN BIOSCIENCES INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $16,810 | -63.0% | 29,648 | -40.3% | 0.00% | – |
| Q1 2023 | $45,433 | -5.1% | 49,654 | +6.9% | 0.00% | – |
| Q4 2022 | $47,861 | -43.0% | 46,467 | +0.3% | 0.00% | – |
| Q3 2022 | $84,000 | +366.7% | 46,334 | +395.9% | 0.00% | – |
| Q2 2022 | $18,000 | -41.9% | 9,343 | +6.4% | 0.00% | – |
| Q1 2021 | $31,000 | +10.7% | 8,782 | -8.8% | 0.00% | – |
| Q4 2020 | $28,000 | +12.0% | 9,625 | +40.5% | 0.00% | – |
| Q3 2020 | $25,000 | -3.8% | 6,852 | +10.9% | 0.00% | – |
| Q2 2020 | $26,000 | +100.0% | 6,178 | +42.4% | 0.00% | – |
| Q1 2020 | $13,000 | -51.9% | 4,338 | -20.8% | 0.00% | – |
| Q4 2019 | $27,000 | +440.0% | 5,476 | +418.1% | 0.00% | – |
| Q3 2019 | $5,000 | -58.3% | 1,057 | -65.0% | 0.00% | – |
| Q2 2019 | $12,000 | -90.6% | 3,022 | -83.6% | 0.00% | – |
| Q1 2019 | $127,000 | – | 18,433 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Leucadia National | 16,600 | $74,202 | 0.00% |
| Cubist Systematic Strategies, LLC | 10,901 | $48,727 | 0.00% |
| UBS Group AG | 6,022 | $26,918 | 0.00% |
| BNP PARIBAS FINANCIAL MARKETS | 3,395 | $15,176 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 21,203 | $94,777 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 1,780 | $7,957 | 0.00% |
| WELLS FARGO & COMPANY/MN | 214 | $956 | 0.00% |
| NORTHERN TRUST CORP | 59,804 | $267,324 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 303,094 | $1,355,169 | 0.00% |